Abstract: Hemodialysis patients can acquire buffer base (i.e., bicarbonate and buffer base equivalents of certain organic anions) from the acid and base concentrates of a three-stream, dual-concentrate, bicarbonate-based, dialysis solution delivery machine. The differences between dialysis fluid concentrate systems containing acetic acid versus sodium diacetate in the amount of potential buffering power were reviewed. Any organic anion such as acetate, citrate, or lactate (unless when combined with hydrogen) delivered to the body has the potential of being converted to bicarbonate. The prescribing physician aware of the role that organic anions in the concentrates can play in providing buffering power to the final dialysis fluid, will have a better knowledge of the amount of bicarbonate and bicarbonate precursors delivered to the patient.
Hemodialysis (HD) uses the conventional threestream, dual-concentrate, bicarbonate-based hemodialysis fluid delivery system (1) (2) (3) . This system consists of an "acid concentrate," a "bicarbonate or base concentrate," and product water.
The acid concentrate contains chlorides of sodium, potassium (optional), calcium, and magnesium; dextrose; as well as an acidifying agent. The latter can be in the form of acetic acid (liquid) (4), citric acid (dry or liquid) (5, 6) , lactic acid (dry) (7), sodium diacetate (dry) (3, 8) , or hydrochloric acid (liquid) (1, 9 ). An acid concentrate usually provides between 2.4 and 5 mM of an acid to the final dialysis solution (3, 10) . Glacial acetic acid, a liquid, remains the most commonly used acidifying agent, not only in a three-stream system (4) , but also in a batch setting (11, 12) . Citric acid remains the only product commercially available in both liquid and dry preparations (5, 6) .
Dry preparations of citric acid-containing (5) and sodium diacetate-containing (8) , acid concentrates have the acid component thoroughly incorporated into the mixture with the other ingredients. A "semi-dry" variety of acetic acid-containing acid concentrate contains all the ingredients in dry form except for acetic acid. Preparation of this acid concentrate requires the initial addition of liquid acetic acid to product water, which is then followed by the introduction of the dry ingredients just prior to the final dialysis fluid's actual use (13). Liquid glacial acetic acid has been employed as the acidifying agent since dry acetic acid does not exist commercially. Dry acetic acid has recently been successfully produced experimentally (14) but has not been used in dialysis as an ingredient to produce acid concentrates yet. The base or bicarbonate concentrate contains sodium bicarbonate (liquid or dry) (15) and sometimes sodium chloride is added to increase conductivity (3, 16) . Since different dialysis fluid and machine manufacturers use different proportioning ratios, there are currently four commonly used ratios for the flow rates of the above described three streams. The ratios for the flow rates among the acid concentrate, bicarbonate concentrate, and product water, respectively, include 1:1.225: 32 (17) (where X denotes the volume of the acid concentrate to be used) (13). For example, using the 45X variety (the number 45 sums up the numbers of 1, 1.72, and 42.28) , and an X of 3 L, after dilution with its accompanying base concentrate and the allotted product water, the final dialysis fluid will have a volume of 45 times 3 5 135 L. The 45X variety has gained popularity because its acid concentrate is the most concentrated, thus reducing the volume of water used to produce the concentrate (when the concentrate is in a liquid form). Moreover, it reduces the cost of transportation as well as fostering easier handling by dialysis personnel. Because of its higher concentration, a given volume of this concentrate will generate more final dialysis fluid than other less concentrated counterparts. Figure 1 depicts the components of a 45X three-stream, dual-concentrate, bicarbonate-based hemodialysis fluid delivery system (2, 3) . The flows of the two concentrates are "coupled." The two concentrates behave like the two arms of a pulley when "coupled." When the flow of one concentrate decreases, that of the other concentrate reciprocally increases (on account of differences in the concentrates' composition and flow rates, the reciprocal changes are necessarily limited in scope and not in a 1:1 ratio), and vice versa (1, 3) . Table 1 illustrates the typical composition of a conventional, three-stream, dual-concentrate, bicarbonate-based dialysis fluid delivery system (13,18).
The 45X preparation (Tables 1 and 2 ) illustrates the acid-base principle underlying the three-stream method (it is of note that the basic principles that apply to a 45X proportioning ratio are also shared by the other proportioning ratio approaches). Let us suppose that the 45X acid concentrate contributes 4 mM acetic acid and the accompanying bicarbonate concentrate contributes 37 mM sodium bicarbonate to the final dialysis solution (13,18). In the latter, when 4 mM acetic acid from the acid concentrate first encounters and mixes with an equimolal amount of sodium bicarbonate (i.e., 4 mM) from the base concentrate (3, 4, (19) (20) (21) (22) the following chemical titration reaction (Eq. 1) takes place. As a result, 4 mM sodium acetate, 33 mM sodium bicarbonate and 4 mM carbonic acid are now present in the final dialysis fluid (20) 
In the above case, the newly formed carbonic acid (i.e., CO 2 gas and water), will lower the final dialysis fluid pH to the neighborhood of 7 (4). The latter pH ensures that the divalent cations in the form of calcium and magnesium in the final dialysis fluid will remain in solution. In an open system, CO 2 gas can disperse from carbonic acid causing an increase in pH. In a closed system, as in the case of most modern dialysis machines, however, CO 2 gas cannot dissipate with ease (16) , although a certain amount may enter the blood. Even if some CO 2 gas might be lost to the blood, the carbonic acid present in the continuously fast-flowing incoming fresh final dialysis fluid can readily keep the dialysis fluid at a desired pH. For example, the 4495.4 mM sodium chloride from the acid concentrate will contribute 4495.4 mM/45 5 100 mM sodium chloride to the final dialysis fluid. The 967.3 mM sodium bicarbonate from the base concentrate will contribute 967.3 mM/26.2 5 37 mM sodium bicarbonate to the final dialysis fluid.
It is noteworthy that some gases are naturally dissolved in water, especially in cold water (24) . Inside a dialysis machine, these gases could come out of solution to form gas bubbles under conditions of negative pressure (e.g., during ultrafiltration) or operating temperature (24) . These bubbles can clog a machine's fluid paths and reduce dialysis efficiency (24, 25) . These dissolved gases can be removed by first exposing product water to a negative pressure and the subsequently released bubbles disposed of by using bubble traps (25) . Since the negative pressure procedure is applied to product water only but not to the final dialysis fluid, the ability of the carbonic acid generated by the above described manner to maintain the desired final dialysis fluid pH will not be affected.
Since 33 mM NaHCO 3 and 4 mM H 2 CO 3 remain after the mixing, the acid-base situation can be illustrated by the Henderson-Hasselbalch equation (3, 26, 27 By changing the amount of acetic acid derived from the acid concentrate and that of sodium bicarbonate obtained from the base concentrate, the pH of the final dialysis fluid can be altered as desired.
In clinical practice, the final dialysis fluid pH can vary from 6.9 to 7.6 (25). The above description forms the basic principle behind the use of the dual concentrates. Mixing the dual concentrates just prior to their actual use for the purpose of dialysis minimizes the loss of CO 2 gas, so that: (a) a desired pH remains within the range of 6.9-7.6, and (b) the bicarbonate in the final dialysis fluid does not lose CO 2 to become carbonate over time (if on prolonged standing) as depicted by: 2NaHCO 3 ! Na 2 CO 3 1 CO 2 "1 H 2 O (28). Without the introduction of carbonic acid (i.e., CO 2 gas) into the final dialysis fluid in the manner mentioned above, a solution containing 37 mM of sodium bicarbonate would have a pH greater than 7.8 (2, 3, 10) . Such a pH would tend to bring about the precipitation of insoluble calcium and magnesium salts. Citric acid, lactic acid, hydrochloric acid, and sodium diacetate behave in a manner similar to that of acetic acid.
A buffer pair can exist as a weak acid and its conjugate salt (29) . An example of such a pair would be carbonic acid and sodium bicarbonate. Bicarbonate per se is often referred to as a buffer base. The organic anions of sodium, potassium, calcium, and magnesium salts include acetate, citrate, lactate, pyruvate, malate, propionate, etc. These organic anions can be converted into bicarbonate in the body (23) and therefore are often called bicarbonate precursors or formers. "Buffering Power" in the present communication refers to the sum of bicarbonate and bicarbonate precursor buffer base.
The fate of organic anions in the body
Organic anions can generate bicarbonate when metabolized into their corresponding acids according to the following reaction (23) The organic acid produced in Eq. 4 may be further broken down in the citric acid cycle to form CO 2 and water (30) . It should be emphasized that, as explained above, organic acids such as acetic, citric, and lactic acids, when introduced into the body, can be metabolized to form carbonic acid (i.e., CO 2 and water). It is obvious then that the above organic acids cannot become bicarbonate. Finally, it is worth stressing that only the conjugate anions of the above organic acids when coupled with cations such as sodium, potassium, calcium, and magnesium can form bicarbonate salts of these cations in the body. Some common examples of these salts used in clinical medicine include sodium lactate present in lactated Ringer's solution (31) and sodium acetate used in parenteral nutrition fluids (32) . Sodium lactate and sodium acetate in these fluids can become sodium bicarbonate if metabolized in the body. In dialysis, sodium acetate was the dominant bicarbonate precursor in hemodialysis fluid for decades before its role was replaced by sodium bicarbonate (33); sodium lactate has been used as the main source of base in peritoneal dialysis (34) and some hemodialysis systems (35, 36) .
As mentioned above, acetic acid (derived from the acid concentrate) titrates an equimolal amount of sodium bicarbonate (derived from the bicarbonate concentrate) to form sodium acetate and carbonic acid in the final dialysis fluid. The newly formed sodium acetate can be converted by the body into sodium bicarbonate when dialyzed into the blood. The above point merits major emphasis because it might be mistakenly believed that acetic acid alone can be metabolized by the body to form bicarbonate, while the significant role played by the cationic hydrogen ion in the acetic acid's molecule might be overlooked. Often only acetate but not acetic acid is listed as an ingredient in some manufacturers' product information sheets. However, some dialysis product manufacturers do properly identify acetic acid as a key component of their acid concentrates and hence of the final dialysis fluid. Please see the information on products manufactured in the United States (13,37) and in Thailand (38) (see Table 1 ).
The fate of dialysis fluid acetate may be clarified by the effect of dialysis on plasma acetate level. Predialysis plasma acetate levels in dialysis patients have been found to range between 0.02 and 1 mmol/ L (9, (39) (40) (41) . In the case of conventional acetic acidcontaining dialysis fluid, the acetate concentration gradient of 3 mM, the difference between 4 mM in dialysis fluid and 1 mmol/L in plasma, should facilitate the entry by diffusion of this anion into the blood during dialysis. The acetate level gradient of 7 mM, the difference between 8 mM of acetate derived from the sodium diacetate of sodium diacetate-containing final dialysis fluid and 1 mmol/L in plasma should also facilitate to a greater extent the entry of acetate into the blood. Plasma acetate level was measured in patients participating in a clinical study in which they were dialyzed with an acetic acid-containing, bicarbonatebased dialysis fluid containing 2-4 mM acetic acid for 4 hours (9). Plasma acetate level increased from a predialysis, baseline mean value of 0.02 mmol/L to a postdialysis mean of 0.22 mmol/L, suggesting that acetate had indeed entered the blood stream during dialysis. In another study, 12 patients received hemodialysis for 5 hours using an acetic acid-containing, bicarbonatebased dialysis fluid having 2-4 mM acetic acid. Two patients with pre-dialysis, baseline plasma acetate levels (measured by the method described by Laker et al. [42] ) of 0.5 and 0.6 mmol/L, respectively achieved post-dialysis plasma acetate levels of 1.7 and 1.5 mmol/ L, respectively, while the remaining patients showed a smaller increase (39) . The above two studies strongly support the notion that acetate (MW 59 dalton and without protein-binding) present in the final dialysis fluid and derived from acetic acid, an ingredient found in the acid concentrate of a bicarbonate-based delivery system, could be dialyzed into the blood stream. Had there not been any concomitant metabolism of dialyzed acetate, the plasma levels of this anion in the above patients would have been higher. Finally, in a major dialysis textbook, Feriani et al. noted that "substances move through the membrane governed by a concentration gradient and affect the final 'net base gain'. In bicarbonate dialysis small amounts of acetic acid are in the dialysate (3-5 mM) creating a flux of acetate into the blood ranging from 0.2 to 0.8 mmol/min. A total of 50-200 mmol acetate per bicarbonate dialysis session can enter the blood (41) ." These authors also pointed out that during such bicarbonate-base dialysis, the mass transfer rate of organic anions generally ranges between 0.2 and 0.5 mmol/min (41).
Methods of calculating buffering power in dialysis fluid
Examples: Method I.
This method applies to dual-concentrates with a label on the base concentrate container
THREE-STREAM HD DELIVERY SYSTEM
specifying an ability to deliver 37 mM bicarbonate to the final dialysis fluid (18) , and a label on the acid concentrate container noting that 4 mM acetic acid will be provided to the final dialysis fluid (13).
Since prior to the mixing between the 4 mM acetic acid from the acid concentrate and the 4 mM sodium bicarbonate from the base concentrate, the label on the base concentrate container claims to possess the capacity to deliver 37 mM sodium bicarbonate to the final dialysis solution, the buffering power prior to mixing would be:
37 mM bicarbonate (pre-mixing) 1 0 mM bicarbonate precursor (pre-mixing) 5 37 mM.
As discussed earlier, the final dialysis solution (i.e., after mixing) would have 33 mM sodium bicarbonate and 4 mM sodium acetate. The buffering power emerging after mixing would then be:
33 mM sodium bicarbonate (post-mixing) 1 4 mM sodium acetate (post-mixing) 5 37 mM.
This buffering power value is the same as that final dialysis fluid bicarbonate level illustrated on the base concentrate container. However, the acetate from the 4 mM sodium acetate can only become bicarbonate if it is dialyzed into the blood and then metabolized by the body.
Method II.
Using the same dual concentrates as described in Method I, many modern dialysis machines display only the post-mixing bicarbonate concentration in the final dialysis fluid on the machines' monitors (10) (the mixing and titration between the 4 mM acetic acid from the acid concentrate and the 4 mM sodium bicarbonate from the base concentrate have already taken place inside the machines ahead of the display; see below). The dialysis machine's displayed bicarbonate concentration represents the prescribed and, hence, the actual dialysis fluid bicarbonate level that will be provided in the dialysis procedure. The displayed bicarbonate level, however, does not include other base buffers such as acetate or citrate which are converted to bicarbonate by the body (10, 43) . In the example chosen here, that post-mixing bicarbonate value would be 37 -4 ð Þ 5 33 mM bicarbonate:
Together with the 4 mM sodium acetate produced after mixing, the buffering power of the final dialysis fluid would be:
33 mM sodium bicarbonate (postmixing) 1 4 mM sodium acetate (postmixing) 5 37 mM, the same value as the final dialysis fluid bicarbonate level that the bicarbonate concentrate was expected to provide (only if the acetate from the 4 mM sodium acetate metabolizes completely to bicarbonate by the body). This "expected" bicarbonate level in the final dialysis fluid of 37 mM appears on the bicarbonate concentrate container label.
It is of note that Methods I and II arrive at similar results.
Dry acid concentrates
Solid concentrates out-perform their liquid counterparts in several areas. Solids weigh less, require less packaging, and take up less storage space resulting in cost savings during shipment and storage. Dry concentrates are easier to handle due to their lighter weight. As a result, accidental injuries, especially from single-patient use concentrates, suffered by dialysis-related personnel tend to be less often and less serious.
Containing citric or lactic acid
Powder preparations of citric acid (5) and lactic acid (7) (not adopted commercially for use in dialysis yet) have been used as the acidifying agents for dry acid concentrates. Since citric and lactic acids are weak organic acids, similar in many chemical reactions to acetic acid per se, the above chemical reactions pertaining to acetic acid apply equally to citric and lactic acids as well.
Containing sodium diacetate (Table 3) (8, 18) In the case of sodium diacetate, however, the situation is different. Powder sodium diacetate consists of approximately equimolal amounts of acetic acid and sodium acetate, with the former accounting by weight for 40% (44) .
In other words, a roughly equimolal contribution of 1:1 means 1 molecule of sodium diacetate (CH 3 COONaÁCH 3 COOH, MW 142 dalton) consists of 1 molecule of acetic acid (CH 3 COOH, MW 60 dalton) and 1 molecule of sodium acetate (CH 3 COONa, MW 82 dalton). The acetic acid component can be used as an acidifying agent. An acid concentrate capable of providing 4 mM sodium diacetate to the final dialysis fluid has been used (8) . The 4 mM sodium diacetate so utilized, therefore, consists of approximately 4 mM acetic acid and 4 mM sodium acetate. As an acidifying agent, those 4 mM acetic acid behave in a manner similar to what has been described above for conventional, acetic acid-containing acid concentrates. The acetate from the 4 mM sodium acetate, that is, the other half of the 4 mM sodium diacetate, however, when dialyzed into blood in part or in whole, can be converted into bicarbonate if metabolized (the same fate of acetate derived from sodium acetate as described above).
There are two ways to calculate the buffering power of a sodium diacetate-containing acid concentrate and its accompanying bicarbonate concentrate.
Pre-mixing buffering power
If the accompanying bicarbonate concentrate of the above sodium diacetate-containing acid concentrate is slated to deliver a pre-mixing bicarbonate level of 37 mM to the final dialysis fluid, the premixing buffering power for this pair of concentrates would be:
37 mM sodium bicarbonate (pre-mixing value; derived from the bicarbonate concentrate, as labeled on the bicarbonate concentrate container) 1 4 mM sodium acetate (from half of the 4 mM sodium diacetate provided by the acid concentrate) 5 41 mM.
Post-mixing buffering power
If post-mixing values are used, the buffering power of this pair of concentrates would be:
33 mM sodium bicarbonate (post-mixing value provided by many modern dialysis machines) 1 4 mM sodium acetate (post-mixing value; derived from the mixing and titration between 4 mM acetic acid [obtained from the 4 mM sodium diacetate of the acid concentrate] and 4 mM sodium bicarbonate [obtained from the bicarbonate concentrate as described above]) 1 4 mM sodium acetate (obtained from the 4 mM sodium diacetate provided by the acid concentrate) 5 41 mM.
In other words, 33 mM sodium bicarbonate 1 8 mM sodium acetate 5 41 mM.
Some modern dialysis machines use this second approach in calculating buffering power (10) . Should the 41 mM buffering power be deemed too high for a particular patient because of the possible deleterious effects of a resultant elevated serum bicarbonate level (45, 46) , one can always use a smaller amount of bicarbonate to constitute the bicarbonate concentrate of a dual-concentrate system that accompanies currently available sodium diacetate-containing acid concentrate capable of delivering 4 mM sodium diacetate to the final dialysis solution (20) . For instance, using a bicarbonate concentrate that delivers 33 mM of sodium bicarbonate instead of 37 mM to the final dialysis fluid can reduce the dialysis fluid bicarbonate load.
It is noteworthy that the 4 mM of sodium diacetate provided to the final dialysis fluid by a currently available sodium diacetate-containing acid concentrate introduces an additional 4 mM sodium to the final dialysis fluid, thus raising the final dialysis fluid sodium concentration to 141 when used in conjunction with a bicarbonate concentrate that delivers 37 mM sodium in the form of sodium bicarbonate (100 mM from the acid concentrate 1 37 mM from the bicarbonate concentrate 1 4 mM from sodium diacetate 5 141 mM sodium concentration [see Table 3 ]). By reducing the bicarbonate concentrate sodium bicarbonate to 33 mM as suggested above one can achieve a final dialysis fluid sodium concentration of 137 mM (100 mM from the acid concentrate 1 33 mM from the bicarbonate concentrate 1 4 mM from sodium diacetate 5 137 mM sodium concentration). This approach will not only curtail the dialysis fluid buffer base impact but will also lower the sodium concentration. The 4 mM sodium gained from the use of sodium diacetate counterbalances the 4 mM sodium lost from the use of a lower sodium bicarbonate level, namely 33 mM, thus ensuring that the dialysis fluid sodium concentration remains at 137 mM.
It has been recently suggested that malnutrition can lead to metabolic alkalosis in dialysis patients (45) , a consequence of consuming less food or eating food that does not metabolize to sulfuric, phosphoric, or organic acids to a large extent (47) (48) (49) . Furthermore, the occurrence of metabolic alkalosis in dialysis patients has been found to be associated with a high mortality rate (46) . In the face of malnutrition-induced metabolic alkalosis, attempts to improve the nutrition deficit should be made and the affected patient should be dialyzed with dialysis fluid that will deliver a lower bicarbonate concentration.
There exists another way of decreasing the delivery of bicarbonate to the final dialysis fluid. Such an approach involves directing a conventional modern dialysis machine to reduce the flow rate of the bicarbonate concentrate. However, as mentioned above, lowering of the bicarbonate concentrate flow rate will lead to a reciprocal increase in the flow rate of the associated acid concentrate. Since (a) large changes in the delivery of an acid concentrate's ingredients (i.e., potassium, calcium, magnesium, hydrogen, acetate, and dextrose) that constitute a final dialysis fluid may not be preferred by some healthcare providers, and (b) there is a need to maintain the sodium concentration of the final dialysis fluid relatively constant (since the levels of sodium in the two concentrates and the flow rates of the concentrates are not equal), the lowest possible dialysis fluid bicarbonate level offered by some modern dialysis machines is only in the realm of 20 mM (10, 43, 50) . Innovative ideas to expand the range of final dialysis fluid bicarbonate levels using a four-stream approach have recently been advanced (51, 52) . In this new proposal, two sodium salt streams of equal sodium levels, namely, a sodium bicarbonate concentrate stream and a sodium chloride concentrate stream (the fourth stream) work together in a pulley-like fashion such that when the delivery of the bicarbonate stream increases, that of the sodium chloride stream will reciprocally decrease (a change of the same magnitude [i.e., a 1:1 ratio] but in the opposite direction), and vice versa. In this approach, the final dialysis fluid bicarbonate value can be widened as desired. Since the two concentrates are isonatric, the final dialysis fluid sodium level will remain unchanged despite changes in the flow rates of the two sodium salt concentrates (51) .
One might wonder whether changing the sodium level in the final dialysis fluid (e.g., during sodium profiling) of a three-stream system would affect the fluid's bicarbonate level. In many dialysis machines, changing the final dialysis fluid sodium level is a function of the reciprocal relationship between the flow rate of the acid concentrate and that of the product water only (43) . Any increase in the acid concentrate flow rate to increase the final dialysis fluid sodium concentration during sodium profiling implies an increase in delivered acetic acid. This increase in acetic acid delivery will result in a decrease in dialysis fluid sodium bicarbonate concentration, a reciprocal increase in sodium acetate concentration, and an increase in carbonic acid formation. This carbonic acid will lower the pH of the final dialysis fluid. The reverse occurs if less acetic acid is delivered to the final dialysis fluid. Whether the final dialysis fluid sodium concentration is increased or decreased in this manner, the total base equivalent (i.e., the sum of bicarbonate and acetate) remains unchanged in the dialysis fluid.
The question has been raised: How does a dialysis machine create a dialysis fluid with a prescribed bicarbonate value? When provided with the required concentrates specifically designed to couple with a particular proportioning ratio system, dialysis machines engineered to function with such concentrates and proportioning ratios can deliver dialysis fluid bicarbonate levels that a healthcare professional prescribes. By adjusting the proportioning ratios of the two concentrates, variations of the delivered bicarbonate level between 20 and 40 mM (10,50) can often be obtained. However, in order to provide a more precise, targeted bicarbonate level, the proportioning ratios that a machine uses need to be highly accurate. Conductivity and pH monitors located at various appropriate sites along the fluid paths can help assure the proper observance of the required proportioning ratios (22, 25) and, hence, the provision of a desired bicarbonate level. It becomes obvious then that dialysis machines do not actually measure dialysis fluid bicarbonate concentrations.
Conductivity is based on the principle that ions in an aqueous solution conduct electricity (53, 54) . The conductivity of a dialysis fluid changes with variations in factors such as concentration (53), dissociation (53), interionic attraction (54), ion mobility (54) , and the ratio between chloride and bicarbonate (24) . A machine's conductivity meter gauges the sum of all the ions in a given area of the dialysis fluid path but does not measure or reflect specific ions or electrolytes (25) .
CONCLUSIONS
In summary, the buffering power of a dialysis fluid includes sodium bicarbonate from the base concentrate and any bicarbonate precursors (e.g., sodium acetate, sodium citrate, sodium lactate, etc.) from either concentrate (examples include: (a) the sodium acetate from sodium diacetate as described above, (b) the addition of sodium citrate [final dialysis fluid level of 0.8 mM] to a base concentrate to promote anti-coagulation (55) , and (c) the small amount of sodium acetate [final dialysis fluid level of 0.3 mM] placed in a citric acid-containing acid concentrate (5,6)). The bicarbonate precursors from either concentrate can transverse the dialyzer membrane and enter the circulation and be converted, at various rates, by the citric acid cycle to bicarbonate. Therefore, the prescribing physician should be familiar with the contribution of these precursors, if any, from either concentrate to the final dialysis fluid total buffer base concentration.
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